Searched for
ANDA PORTFOLIO
Senores Pharma to acquire 14 ANDAs from Dr Reddy's LaboratoriesSenores Pharmaceuticals of Gujarat has signed an agreement to acquire 14 Abbreviated New Drug Applications from Dr Reddy's Laboratories. Th...04 Mar, 2025, 04.51 PM IST- Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US"The over-the-counter market has long been an important segment of Glenmark's portfolio around the world. Our acquisition of these ANDAs re...28 Jun, 2022, 12.13 PM IST
- Zydus Cadila gets USFDA nod for cancer and high blood pressure, treatment drugZydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of ...08 Apr, 2021, 11.25 AM IST
- Dr Reddy's acquires a portfolio of 42 ANDAs in USThese products will require to be technology transferred and could be launched within the next one to two years.13 Apr, 2019, 10.19 PM IST
- There’s hope yet for Sun investorsThe disappointment was accentuated as Q2 results came after encouraging results in the preceding two quarters.14 Nov, 2018, 08.55 AM IST
- Ajanta Pharma gets USFDA nod for Parkinson's disease tabletIn a BSE filing, Ajanta Pharma said it has recieved "final approval for Entacapone tablets from US FDA. It is a bioequivalent generic versi...04 Sep, 2017, 11.21 AM IST
- Ajanta Pharma launches BP lowering tablets in USAjanta Pharma's Amlodipine + Olmesartan Medoxomil tablets are a generic version of Daiichi Sankyo Inc's Azor tablets02 Nov, 2016, 06.05 PM IST
- Dr Reddy's joins hands with Gland Pharma to market 8 ANDAs in USDr Reddy's is developing its injectable business and recently launched Paricalcitol injection, a therapeutic equivalent generic version of ...26 Oct, 2016, 10.47 PM IST
- Zydus Healthcare buys 2 ANDAs from TevaThe company said these ANDAs have been acquired by its 100 per cent subsidiary, Zydus Worldwide DMCC and will be financed through the group...20 Jun, 2016, 12.18 PM IST
- Neutral Dr Reddy's Laboratories, target Rs 3200: Motilal OswalTeva is divesting the portfolio as a pre-condition to close the Allergan deal (due to overlap). The acquisition of these ANDAs is contingen...15 Jun, 2016, 01.48 PM IST
- Dr. Reddy’s buys eight ANDAs from Teva for $350 millionDr. Reddy’s said the acquisition of ANDAs is contingent on closing of the Teva generics transaction and approval by the US Federal Trade Co...11 Jun, 2016, 01.01 PM IST
- Lupin looking to enter new product segments, geographies: MD Nilesh GuptaIn order to consolidate its business globally, the Mumbai-based firm has already inked various agreements in the previous fiscal.29 Jun, 2015, 03.50 PM IST
- Lupin to beef up branded portfolio through alliances and strategic brand acquisitionsLupin is looking at strengthening its branded portfolio by creating alliances and eyeing strategic brand acquisitions in US markets in 2015...28 Jun, 2015, 12.47 PM IST
- Glenmark Generics gets US FDA nod for ulcer treatment drugGlenmark's current portfolio consists of 94 products authorised for distribution in the US market and 72 ANDAs are pending approval with th...05 Nov, 2014, 05.03 PM IST
- Glenmark receives ANDA approval for its contraceptive pillsGlenmark Generics Inc., USA, a subsidiary of Glenmark Glenmark on Monday announced they have been granted final approval for their abbrevia...09 Apr, 2012, 04.45 PM IST
- Glenmark gets first nod for Zetia genericGlenmark Pharmaceuticals has got tentative approval from the USFDA for the generic version of Schering Plough and MSP Singapore Company LLC...27 Apr, 2009, 03.44 PM IST
- Glenmark's US arm in $27m-deal with Paul CapitalThe US subsidiary of Glenmark Pharmaceuticals (Glenmark) has signed a $27m deal with Paul Capital Partners’ Royalty Fund.06 Jun, 2006, 12.00 AM IST
Load More
